Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Forget Eli Lilly: 3 Biotech Stocks to Buy Instead
July 04, 2024
Eli Lilly is a good stock to buy, but these should be even better.
Via
The Motley Fool
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
July 03, 2024
The S&P 500 and Nasdaq 100 indices surged to new all-time highs on Thursday, as investors heightened their expectations for rate cuts following June’s sharply lower-than-expected services sector...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
July 03, 2024
The study comes out of a Harvard teaching hospital based in Boston.
Via
Investor's Business Daily
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
July 03, 2024
The FDA has approved Eli Lilly's Kisunla (donanemab) for early symptomatic Alzheimer's disease. Kisunla, targeting amyloid plaques, shows a significant reduction in disease progression and may reduce...
Via
Benzinga
Exposures
Product Safety
'Other Bets' Startup Mineral Bites The Dust In Google Cost Cutting Move
July 03, 2024
Alphabet said it's shuttering agricultural startup Mineral, one of its "Other Bets" ventures, in a cost-cutting move for Google stock.
Via
Investor's Business Daily
Top 3 Health Care Stocks That May Crash This Quarter
July 03, 2024
Via
Benzinga
Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer?
July 03, 2024
Clinical-state biopharmaceutical company Altimmune Inc. (NASDAQ: ALT) focuses on developing peptide-based therapeutics for obesity and chronic liver diseases
Via
MarketBeat
Exposures
Product Safety
These 4 Vanguard ETFs Soared Over 20% in the First Half of 2024. Here's Which One Is Most Likely to Fly Even Higher.
July 03, 2024
These Vanguard ETFs have a lot in common.
Via
The Motley Fool
Topics
ETFs
Eli Lilly Shares Gain After Drug-Maker Gets FDA's Nod For Early Alzheimer's Treatment
July 03, 2024
The treatment is intended for adults in the early symptomatic stages of Alzheimer's disease.
Via
Benzinga
Exposures
Product Safety
Eli Lilly Receives FDA Approval For Its Alzheimer’s Drug Kinsula
July 03, 2024
Eli Lilly & Co received approval for its Alzheimer’s drug from the Food & Drug Administration on Tuesday. The development is significant as it expands treatment options for the neurological disorder...
Via
Talk Markets
Exposures
Product Safety
Tesla, Paramount Global, Annovis Bio, Eli Lilly, Amazon: Why These 5 Stocks Are On Investors' Radars Today
July 02, 2024
On Tuesday, the Dow Jones Industrial Average rose by 0.4%, closing at $39,331.85, while the S&P 500 also ended the day in positive territory.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AMZN Stock Outlook: Amazon’s Next Growth Wave Could Make Early Investors Rich
July 02, 2024
After effectively eliminating a threat from low-cost Chinese e-commerce websites and Amazon stock remains attractive.
Via
InvestorPlace
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
July 02, 2024
The company is on deck to rival Biogen and Eisai's Leqembi.
Via
Investor's Business Daily
How Great Is It to Have Customers That Absolutely Love You and Plan to Never Leave You?
July 02, 2024
We also talk about weight loss drugs and sleep apnea, and other stock market news.
Via
The Motley Fool
Joe Biden Suggests Novo Nordisk, Eli Lilly To Lower Prices For Its Popular Obesity Drugs
July 02, 2024
American leaders push for lower drug prices, highlighting recent legislation and widespread support for affordable medications. The Inflation Reduction Act caps insulin costs and Medicare now...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Novo, Lilly Dive After Biden Slams Duo For 'Unconscionably High' Drug Prices
July 02, 2024
The duo make weight-loss and diabetes drugs that sell for more than $1,000 a month before insurance kicks in.
Via
Investor's Business Daily
Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes
July 02, 2024
Pharmaceutical giant Pfizer Inc. (NYSE: PFE) has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy
Via
MarketBeat
3 Under-the-Radar Biotech Stocks With Blockbuster Potential
July 02, 2024
Are you looking to boost your portfolio with the best under-the-radar biotech stocks? Here are the top three.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
July 01, 2024
Via
Benzinga
Sanofi Nears Decision on $1.6B Upgrade For Frankfurt Insulin Plant
July 01, 2024
Sanofi is set to invest up to $1.6 billion in its Frankfurt insulin production site, marking a significant win for Germany's healthcare sector. Recent investments by Daiichi Sankyo and Eli Lilly...
Via
Benzinga
Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
July 01, 2024
Global pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) has made headlines with its leading GLP-1 weight loss drugs, Mounjaro and Zepbound.
Via
MarketBeat
Exposures
Product Safety
Eli Lilly Soars To 52-Week High: Can The Momentum Continue?
July 01, 2024
Eli Lilly is up a remarkable 97.38% over the past year and 55.32% year-to-date. Strong technical indicators suggest continued momentum.
Via
Benzinga
Is Google Stock A Buy With Earnings Due, New CFO Waiting In The Wings?
July 01, 2024
Up big in 2024 on AI buzz, Google reports earnings in July with a new CFO set to take over.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Nvidia Among Biggest Stock Market Winners In 2024, But This Is No. 1
July 01, 2024
Several AI stocks among the S&P 500's best performers.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Want Decades of Passive Income? 2 Top Dividend Stocks to Buy Now and Hold Forever.
July 01, 2024
These stalwart companies could help you safely grow your wealth.
Via
The Motley Fool
2 Top Healthcare Stocks to Buy in June
June 30, 2024
Healthcare businesses tend to hold up through various economic cycles.
Via
The Motley Fool
Sound Investments: 3 Stocks to Buy for a Good Night’s Rest
June 29, 2024
The safe stocks to buy for a good night’s rest aren’t the kind you’re thinking about. Nonetheless, they do make worthwhile investments.
Via
InvestorPlace
This Is Massive News for Eli Lilly Investors
June 29, 2024
A panel of advisors to the Food and Drug Administration (FDA) recently recommended Eli Lilly's Alzheimer's candidate.
Via
The Motley Fool
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
June 29, 2024
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk.
Via
InvestorPlace
Eli Lilly Is Teaming Up With OpenAI. Here Are 3 Things Smart Investors Should Know.
June 29, 2024
Eli Lilly is the latest major pharmaceutical company to bring artificial intelligence (AI) to the healthcare sector.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
< Previous
1
2
...
11
12
13
14
15
16
17
18
19
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.